Skip to content
DataLookout
Menu

Changes this week

Changes detected in the 7 days to Nov 21, 2026

  1. Minor: Specified Drug-use Survey of Leqvio for s.c. Injection Trial completed Novartis PharmaceuticalsNot specified NCT06275724
  2. Minor: Probiotic Supplementation on Stress and Anxiety in Students Trial completed Nordic Biotic Sp. z o.o.Not applicable NCT07470645
  3. Minor: Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial Enrollment closed, study ongoing Edwards LifesciencesNot applicable NCT04097145
  4. Minor: Gastrointestinal Discomfort and Infections in Healthy Term Infants Trial completed Ausnutria Hyproca B.V.Not specified NCT06744699
  5. Minor: Specified Drug-use Surveillance of Fabhalta Capsules Trial completed Novartis PharmaceuticalsNot specified NCT06606314
  6. Minor: New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors Enrollment closed, study ongoing National Cancer Institute (NCI)Phase 1/2 NCT05053971
  7. Minor: 9-Valent Human Papillomavirus Recombinant Vaccine · Idiopathic CD4 T Cell Lymphocytopenia Trial completed National Institute of Allergy and Infectious Diseases (NIAID)Phase 2 NCT03519464
  8. Minor: Emicizumab · Type 3 Von Willebrand Disease Primary completion pushed from Apr 30, 2027 to Oct 6, 2027 Hoffmann-La RochePhase 3 NCT06998524
  9. Minor: Duration of Dostarlimab in Untreated Mismatch Repair Deficient (dMMR)/ Microsatellite Instability-high (MSI-H) Locally Advanced Rectal Cancer Primary completion pushed from Dec 12, 2029 to Mar 13, 2030 GlaxoSmithKlinePhase 3 NCT07740720
  10. Minor: IBDminds - Mapping the Influence of aNxiety and DepreSsion on IBD Trial status changed: Not Yet Recruiting → Active, Not Recruiting The Royal Wolverhampton Hospitals NHS TrustNot specified NCT07175454
  11. Minor: Proximal Versus Distal Superior Cluneal Nerve Block in Entrapment Neuropathy Trial completed Gaziosmanpasa Research and Education HospitalNot specified NCT07372430
  12. Minor: Mosunetuzumab · Systemic Lupus Erythematosus With or Without Active Lupus Nephritis Primary completion pushed from Feb 28, 2028 to Aug 11, 2028 Hoffmann-La RochePhase 2 NCT07598396
  13. Minor: Bioavailability of Phlorotannins and Carotenoids Following the Intake of Crackers Fortified With Seaweed Trial completed National Research Council, SpainNot applicable NCT07508735
  14. Minor: Financial Navigation Program to Improve Understanding and Management of Financial Aspects of Cancer Care for Patients and Their Spouses Sponsor refiled this as active, not recruiting (was completed) SWOG Cancer Research NetworkNot applicable NCT04960787
  15. Minor: Dexmedetomidinine · Postoperative Delirium in the Intensive Care Unit After Cardiac Surgery Trial completed University of Novi SadPhase 3 NCT05849597
  16. Minor: Dexmedetomidine in Postoperative Analgesia Trial status changed: Enrolling by Invitation → Completed New Valley UniversityPhase 2/3 NCT05705128
  17. Minor: Nuwiq for Perioperative Management · Haemophilia A on Emicizumab Regular Prophylaxis Study Primary and study completion dates pushed to Dec 2026 OctapharmaPhase 4 NCT05935358
  18. Minor: Pre-Emptive Parecoxib Sodium for Pain Control During CT-Guided Lung Nodule Localization Enrollment closed, study ongoing Long JiangPhase 4 NCT07675473
  19. Minor: ACTEMRA® · Pediatric Adamantinomatous Craniopharyngioma Enrollment closed, study ongoing Nationwide Children's HospitalPhase 2 NCT05233397
  20. Minor: Ferric Citrate and Chronic Kidney Disease in Children Enrollment closed, study ongoing University of California, Los AngelesPhase 2 NCT04741646
  21. Minor: OSE2101 Alone or in Combination With Pembrolizumab vs BSC · Platinum-sensitive Recurrent OC Trial completed ARCAGY/ GINECO GROUPPhase 2 NCT04713514
  22. Minor: Post-operative Analgesic Effect of Oral Nefopam Enrollment closed, study ongoing Hospices Civils de LyonPhase 2 NCT04576078
  23. Minor: Dichloroacetate (DCA) in Glioblastoma Multiforme (GBM) Trial completed University of FloridaPhase 2 NCT05120284
  24. Minor: Herbal Supplement (Biocidin REMOVE) for Bacterial Overgrowth in Irritable Bowel Syndrome Trial status changed: Enrolling by Invitation → Recruiting Johns Hopkins UniversityPhase 2 NCT07768267
  25. Minor: Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion Enrollment closed, study ongoing Nationwide Children's HospitalEarly Phase 1 NCT04655404